Plain-English, evidence-led explainers on the compounds behind every goal — what they are, what the research says, what’s legal in Australia, and exactly what to ask a registered doctor. Information, not hype.
Testosterone Replacement Therapy restores testosterone to a normal range in people with a clinically diagnosed deficiency. Done properly it is a long-standing, well-understood medical treatment — not a shortcut.
Read the guide →Semaglutide is a TGA-registered, prescription-only GLP-1 receptor agonist used for type 2 diabetes (Ozempic) and chronic weight management (Wegovy). Large STEP trials showed average weight loss of roughly 15% over 68 weeks.
Read the guide →Tirzepatide (Mounjaro) is a TGA-registered, prescription-only dual GIP/GLP-1 receptor agonist approved for type 2 diabetes and chronic weight management. SURMOUNT trials showed average weight loss of roughly 13–23%.
Read the guide →BPC-157 is a synthetic peptide studied mainly in animals for tissue repair. In Australia it is not an approved medicine, is treated as prescription-only/compounded, and is banned in sport.
Read the guide →TB-500 is a synthetic peptide related to the natural protein Thymosin Beta-4, studied mainly in animals for repair and wound healing. In Australia it is unapproved, prescription-only/compounded, and banned in sport.
Read the guide →CJC-1295 is a synthetic, long-acting analogue of growth-hormone-releasing hormone (GHRH) studied for its ability to raise growth hormone and IGF-1. In Australia it is a prescription-only (Schedule 4) compounded peptide, not registered on the ARTG.
Read the guide →Ipamorelin is a synthetic peptide that mimics ghrelin to stimulate growth hormone release, valued in research for its selectivity. In Australia it is a prescription-only (Schedule 4) compounded peptide, not registered on the ARTG.
Read the guide →NAD+ is a coenzyme central to energy metabolism and cellular repair that declines with age. Supplements and IV products aim to raise it, but most longevity claims remain preliminary.
Read the guide →PT-141 (bremelanotide) is a melanocortin receptor agonist studied for low sexual desire. It is US-approved as Vyleesi for HSDD in premenopausal women and is prescription-only and compounded in Australia.
Read the guide →SLU-PP-332 is an experimental synthetic compound (an estrogen-related receptor agonist) studied in animals as a possible "exercise mimetic." It is not approved for human therapeutic use anywhere, and almost all evidence is preclinical.
Read the guide →MOTS-c is a naturally occurring mitochondrial-derived peptide being studied, mostly in animals, for effects on metabolism and exercise capacity. As an injected research product it is not approved for human therapeutic use in Australia and remains experimental.
Read the guide →